Provided by Tiger Trade Technology Pte. Ltd.

Kestra Medical Technologies Inc

25.14
-0.6100-2.37%
Volume:195.43K
Turnover:5.02M
Market Cap:1.47B
PE:-10.35
High:26.19
Open:25.54
Low:25.14
Close:25.75
52wk High:30.00
52wk Low:15.42
Shares:58.35M
Float Shares:30.74M
Volume Ratio:1.01
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4290
EPS(LYR):-2.4290
ROE:-56.60%
ROA:-25.75%
PB:5.65
PE(LYR):-10.35

Loading ...

Earnings Flash (KMTS) Kestra Medical Technologies Posts Fiscal Q4 Per-Share Loss $0.67, vs. FactSet Est of Loss $0.59

MT Newswires Live
·
Jul 15

GUIDANCE: (KMTS) Kestra Medical Technologies Expects Fiscal 2027 Revenue $137M, vs. FactSet Est of $132.9M

MT Newswires Live
·
Jul 15

Kestra Medical Technologies - Term Loan Provides 48 Months Interest-only Payments, Extendable by 12 Months on Revenue Milestone

THOMSON REUTERS
·
Jul 15

Kestra Medical Technologies - Enters Five-year Term Loan Facility with Pharmakon Advisors

THOMSON REUTERS
·
Jul 15

Kestra Medical Technologies Secures up to $200 Million of Non-dilutive Financing

THOMSON REUTERS
·
Jul 15

Kestra Medical Techs Q4 EPS $(0.67) Misses $(0.59) Estimate, Sales $28.638M Beat $26.479M Estimate

Benzinga Earnings
·
Jul 15

Kestra FY26 Net Loss Widens to $131.61 Million; Revenue Rises 59% to $95.1 Million

Reuters
·
Jul 15

Kestra Medical Technologies Inc Q4 Adjusted Ebitda USD -26.7 Million VS. Ibes Estimate USD -22.5 Million

THOMSON REUTERS
·
Jul 15

Kestra Medical Technologies Inc Q4 Revenue USD 28.638 Million VS. Ibes Estimate USD 26.5 Million

THOMSON REUTERS
·
Jul 15

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results

THOMSON REUTERS
·
Jul 15

Top News Today: Stocks Fall as Chip Makers Slide, Oil Spikes

Dow Jones
·
Jul 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 10

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 08

Earning Preview: Kestra Medical Technologies Inc this quarter’s revenue is expected to increase by 68.10%, and institutional views are cautious

Earnings Agent
·
Jul 07

Kestra Medical Technologies to Report Q4 Fiscal 2026 Results After Market Close

Reuters
·
Jul 01

Kestra Medical CEO Brian Daniel Webster sells 15,000 common shares for $312,142.5

Reuters
·
Jun 18

Kestra CEO Brian Daniel Webster disposes of common shares worth $315,833

Reuters
·
May 19

Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Apr 29

Kestra to exhibit at Heart Rhythm Society annual meeting, showcase Cardiac Recovery System

Reuters
·
Apr 22